Pfizer, Moderna: is there a lack of “hindsight” on RNA vaccines against Covid?
THE CHEKING PROCESS – While being in favor of vaccination in general against Covid, Prof. Eric Caumes maintains his doubts concerning this new technology.
THE QUESTION. The statements of this professor of medicine, who is not part of the “anti-vaccine», Had caused a stir last week. Professor Eric Caumes, head of the infectious disease department at the Pitié-Salpêtrière hospital in Paris, considered that there was a lack of “recoilOn RNA vaccines, this new technology which is based on the injection of strands of the virus’s genetic code to trigger an immune reaction of the body against the same virus. That of Pfizer / BioNTech is the first vaccine against Covid to have been announced, on November 18, by the American pharmaceutical group and its German partner as a success. It is already administered in the United Kingdom, the first country to have launched its vaccination campaign. That of Moderna, another American laboratory, followed shortly after by announcing the first results.
Professor Eric Caumes then criticized Pfizer and Moderna for relying only on press releases when the vaccine had not yet
This article is for subscribers only. You have 90% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
Already subscribed? Log in